This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays

Savings Deadline Ends In:

  • 00
  • 00
  • 00
  • 00
November 1-3, 2022
College Park Marriott Hotel & Conference CenterHyattsville, Maryland, USA

Elisabeth Krug
Principal Research Scientist at Eli Lilly & Company


Dr. Elisabeth Krug graduated from the University of Würzburg, Germany, in 1994 as a pharmaceutical biologist. She started with Lilly in 1995 as an analytical scientist in the small molecule development. She then took an assignment in Six Sigma becoming a Master Black Belt. Since 2010, Dr. Krug has been extensively working with biomolecules, where she is responsible to support the analytical development and control strategy definition for biomolecules. Since 2020 she has been involved more deeply with the potency determination heading the bioassay development group.

Agenda Sessions

  • Chairperson's Welcome and Opening Remarks